The price of Abilify injections can vary significantly depending on factors such as dosage, quantity, insurance coverage, and the pharmacy where it is purchased. Without insurance, a single vial of Abilify Maintena (aripiprazole monohydrate) for intramuscular injection can range from approximately $1,000 to over $2,000 [1].
How much does Abilify Maintena cost with insurance?
Insurance coverage can substantially reduce out-of-pocket costs for Abilify Maintena. Many insurance plans have co-pays that range from $10 to $100 per prescription, but this is highly dependent on the specific plan and formulary. Patients are advised to check with their insurance provider for precise coverage details and co-pay amounts. Manufacturer assistance programs may also be available to help eligible individuals reduce their costs.
What are the available dosages for Abilify injections?
Abilify Maintena is available in intramuscular injection forms with dosages of 300 mg/2 mL and 400 mg/2 mL [2]. These are typically administered monthly by a healthcare professional.
When does the patent for Abilify expire?
The patent landscape for Abilify is complex, with various patents covering different aspects of the drug, including its formulation and method of use. Some of the key patents for the oral form of Abilify expired several years ago, allowing for generic versions. However, patents related to the injectable formulations, like Abilify Maintena, have later expiration dates [3]. DrugPatentWatch.com tracks patent expirations and potential market entry dates for generic and biosimilar drugs [4].
Can generic Abilify injections be made available?
The development of generic versions of injectable medications like Abilify Maintena is subject to patent expirations and regulatory approval processes. Once relevant patents expire and regulatory hurdles are cleared, generic manufacturers may be able to produce and market their own versions of the drug.
What is the difference between Abilify and Abilify Maintena?
Abilify is the brand name for aripiprazole, available in oral tablet and orally disintegrating tablet forms, and is typically taken daily. Abilify Maintena is a long-acting injectable formulation of aripiprazole, designed for monthly administration by a healthcare provider. This extended-release formulation helps maintain stable drug levels over time, potentially improving adherence for some patients [2].
Who manufactures Abilify and Abilify Maintena?
Abilify and Abilify Maintena were originally developed by Otsuka Pharmaceutical. The drug is marketed in the United States by Bristol Myers Squibb.
What are the approved uses for Abilify injections?
Abilify Maintena is approved for the treatment of schizophrenia in adults and for maintenance treatment of bipolar I disorder in adults [2].
---
Sources:
[1] GoodRx. (n.d.). Abilify Maintena Prices, Coupons & Savings Tips. Retrieved from https://www.goodrx.com/abilify-maintena
[2] FDA. (n.d.). Abilify Maintena Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205405s025lbl.pdf
[3] DrugPatentWatch. (n.d.). Aripiprazole Patent Expirations. Retrieved from https://drugpatentwatch.com/aripiprazole
[4] DrugPatentWatch. (n.d.). About Us. Retrieved from https://drugpatentwatch.com/about